Recent publications on Cancer

Spangler L, Yu O, Loggers E, Boudreau DM. Bone mineral density screening among women with a history of breast cancer treated with aromatase inhibitors.  J Womens Health (Larchmt). 2013 Feb;22(2):132-40. doi: 10.1089/jwh.2012.3687. Epub 2013 Jan 30. PubMed

Passarelli MN, Phipps AI, Potter JD, Makar KW, Coghill AE, Wernli KJ, White E, Chan AT, Hutter CM, Peters U, Newcomb PA. Common single nucleotide polymorphisms in the estrogen receptor beta promoter are associated with colorectal cancer survival in postmenopausal women.  Cancer Res. 2013 Jan 15;73(2):767-75. doi: 10.1158/0008-5472.CAN-12-2484. Epub 2012 Nov 13. PubMed

Carlson JJ, Roth JA. The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013 Aug;141(1):13-22. doi: 10.1007/s10549-013-2666-z. Epub 2013 Aug 24. Erratum in: Breast Cancer Res Treat. 2014;146(1):233. doi: 10.1007/s10549-014-3009-4. PubMed

Elena JW, Steplowski E, Yu K, Hartge P, Tobias GS, Brotzman MJ, Chanock SJ, Stolzenberg-Solomon RZ, Arslan AA, Bueno-de-Mesquita HB, Helzlsouer K, Jacobs EJ, LaCroix A, Petersen G, Zheng W, Albanes D, Allen NE, Amundadottir L, Bao Y, Boeing H, Boutron-Ruault MC, Buring JE, Gaziano JM, Giovannucci EL, Duell EJ, Hallmans G, Howard BV, Hunter DJ, Hutchinson A, Jacobs KB, Kooperberg C, Kraft P, Mendelsohn JB, Michaud DS, Palli D, Phillips LS, Overvad K, Patel AV, Sansbury L, Shu XO, Simon MS, Slimani N, Trichopoulos D, Visvanathan K, Virtamo J, Wolpin BM, Zeleniuch-Jacquotte A, Fuchs CS, Hoover RN, Gross M. Diabetes and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium. Cancer Causes Control. 2013 Jan;24(1):13-25. doi: 10.1007/s10552-012-0078-8. Epub 2012 Oct 31. PubMed

Dillard AJ, Scherer L, Ubel PA, Smith DM, Zikmund-Fisher BJ, McClure JB, Greene S, Stark A, Fagerlin A. Breast cancer anxiety's associations with responses to a chemoprevention decision aid. Soc Sci Med. 2013 Jan;77:13-9. doi: 10.1016/j.socscimed.2012.10.009. Epub 2012 Nov 2. PubMed

Fenton JJ, Miglioretti DL. Why we need more breast cancer screening trials. Evid Based Med. 2012 Dec;17(6):169-70. doi: 10.1136/eb-2012-100869. Epub 2012 Jul 31. PubMed

Ritzwoller DP, Carroll N, Delate T, Hornbrook MC, Kushi L, Aiello Bowles EJ, Freml JM, Huang K, Loggers ET. Patterns and predictors of first-line chemotherapy use among adults with advanced non-small cell lung cancer in the Cancer Research Network. Lung Cancer. 2012 Dec;78(3):245-52. doi: 10.1016/j.lungcan.2012.09.008. Epub 2012 Sep 27. PubMed

Hubbard RA, Zhu W, Onega TL, Fishman P, Henderson LM, Tosteson AN, Buist DS. Effects of digital mammography uptake on downstream breast-related care among older women.  Med Care. 2012;50(12):1053-9. PubMed

Shinohara ET, Mitra N, Fei W, Kirschner AN, Metz JM. Trends in the use of postoperative radiation therapy in patients with localized resectable pancreatic cancer. Am J Clin Oncol. 2012 Dec;35(6):543-8. doi: 10.1097/COC.0b013e31822dfd3c. PubMed

Smith RA, Kerlikowske K, Miglioretti DL, Kalager M. Clinical decisions. Mammography screening for breast cancer. N Engl J Med. 2012 Nov 22;367(21):e31. doi: 10.1056/NEJMclde1212888. PubMed

Patel R, Klasnja P, Hartzler A, Unruh K, Pratt W. Probing the benefits of real-time tracking during cancer care. AMIA Annu Symp Proc. 2012;2012:1340-9. Epub 2012 Nov 3. PubMed

Aiello Bowles EJ, Boudreau DM, Chubak J, Yu O, Fujii M, Chestnut J, Buist DS. Patient reported discontinuation of endocrine therapy and related side effects among women with early stage breast cancer. J Oncol Prac. Nov 1 2012:e149-57. PubMed

Onega T, Smith M, Miglioretti DL, Carney PA, Geller BA, Kerlikowske K, Buist DS, Rosenberg RD, Smith RA, Sickles EA, Haneuse S, Anderson ML, Yankaskas B. Radiologist agreement for mammographic recall by case difficulty and finding type.  J Am Coll Radiol. 2012;9(11):788-94. doi: 10.1016/j.jacr.2012.05.020. PubMed

O'Farrell CM, Green BB, Reid RJ, Bowen D, Baldwin LM. Physician-patient colorectal cancer screening discussions by physicians' screening rates. J Am Board Fam Med. 2012 Nov;25(6):771-81. doi: 10.3122/jabfm.2012.06.110279. PubMed

Goddard KA, Aiello Bowles EJ, Spencer Feigelson H, Habel LA, Alford SH, McCarty CA, Nekhlyudov L, Onitilo AA, Rahm AK, Webster JA. Utilization of HER2 genetic treating in a multi-institutional observational study. Am J Manag Care. 2012 Nov;18(11):704-12. PubMed

Shan L, Chen YA, Davis L, Han G, Zhu W, Molina AD, Arango H, LaPolla JP, Hoffman MS, Sellers T, Kirby T, Nicosia SV, Sutphen R. Measurement of phospholipids improve diagnostic accuracy in ovarian cancer. PLoS One. 2012;7(10):e46846. doi: 10.1371/journal.pone.0046846. Epub 2012 Oct 17. PubMed

Mazor KM, Rogers HJ, Williams AE, Roblin DW, Gaglio B, Field TS, Greene SM, Han PK, Costanza ME. The Cancer Message Literacy Tests: psychometric analyses and validity studies. Patient Educ Couns. 2012 Oct;89(1):69-75. doi: 10.1016/j.pec.2012.06.018. Epub 2012 Jul 11. PubMed

Carlos RC, Buist DS, Wernli KJ, Swan JS. Patient-centered outcomes in imaging: quantifying value.  J Am Coll Radiol. 2012;9(10):725-8. doi: 10.1016/j.jacr.2012.06.008. PubMed

Ferreira BP, Rodler ET, Loggers ET, Pollack SM, Jones RL. Systemic therapy in primary angiosarcoma of the spleen. Rare Tumors. 2012 Oct 10;4(4):e55. doi: 10.4081/rt.2012.e55. Epub 2012 Nov 13. PubMed

Yasmeen S, Hubbard R, Romano PS, Zhu W, Geller BM, Onega T, Yankaskas B, Miglioretti DL, Kerlikowske K. Risk of advanced-stage breast cancer among older women with comorbidities. Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1510-9. Epub 2012 Jun 28. PubMed